Abstract
In a search for new variables, for the diagnosis of disseminated intravascular coagulation (DIC) and for guidelines of therapy in such conditions, 22 severely ill patients were studied. The diagnosis of DIC was based on determinations of platelet counts, prothrombin complex (Normotest), antithrombin (AT), fibrinogen degradation products and fibrinogen. Nine patients were diagnosed as having DIC, eight patients were referred to a suspected DIC group and five to a group of no DIC. The laboratory findings were found to agree with the clinical status. In addition several new parameters were investigated: factor XII, prekallikrein, Simplastin A — another prothrombin complex factor method, factor X, plasminogen (PLG), antiplasmin (AP) and kallikrein inhibitors (KI). Platelet counts, prothrombin complex and antithrombin were mostly pathological in DIC-patients. Of the alternative tests prothrombin complex, fibrinopeptide A and the kallikrein inhibitor as well as the two tests for fibrinolysis (PLG and AP) were significantly altered in DIC-patients. The inhibitor capacity (AT, APV and KI) was lower in patients who died than in survivors and decreased still further in those of the non-survivors who had DIC. Thus the inhibitors can be used as predictors of outcome and hopefully for guiding therapy. To establish the diagnosis of DIC we suggest measurement of platelet count, prothrombin complex, plasminogen as well as of the inhibitors.
Similar content being viewed by others
References
Abildgaard U (1981) Antithrombin and related inhibitors of coagulation pp. 151–174 in Recent Advances in Blood Coagulation No. 3 (Ed L Poller) Churchill Livingstone
Blombäck M, Eklund J, Hellgren M, Lagerkranser M, Swedenborg J (1983/84) Blood coagulation and fibrinolytic factors and their inhibitors in trauma. Intensive Care Med (in press)
Damus PS, Vallage GA (1975) Immunological measurement of antithrombin III-heparin co-faktor and α2-macroglobilin in disseminated intravascular coagulation and hepatic failure coagulopathy. Thromb Res 6:27
Egberg N, Bergström K (1978) Studies on assays for plasma prekallikrein and for the monitoring of coumarol therapy. Haemostasis 7:85
Egberg N, Övermark I (1983/84) Assay for Hageman factor by means of chromogenic substrate. Thromb Res (in press)
Friberger P, Knös M, Gustavsson S, Aurell L, Cleason G (1978) Methods for determination for plasma antiplasmin and plasminogen by means of substrate S-2251. Haemostasis 7:138
Gallimore MJ, Friberger P (1978) Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein like activity in human plasma. Thromb Res 25:293
Hehne HJ, Hyman P, Burri H, Wolff G (1976) Frischgefrorenes konserviertes Plasma zur Behandlung der intravasalen Gerinnung beim Polytraumatisierten. Schweiz Med Wochensch 106:671
Hedner U, Nilsson IM (1972) Parallel determination of FDP and fibrinomonomers with various methods. Thromb Diathes Haemorrh 28:268
Kaplan PA, Meier HL, Mandle R Jr (1976) The Hageman factor dependent pathways of coagulation, fibrinolysis and kinin generation. Semin Thromb Haemost 3:1
Kudryk B, Robinson D, Netre C, Hessel B, Blombäck M, Blombäck B (1982) Measurement in human blood of fibrinogen/fibrin fragments containing the Bß 15–42 sequence. Thromb Res 25:277
Larsson R, Eriksson JC, Lagergren H, Olsson P (1979) Platelet and plasma coagulation compatibility of heparinized and sulphatated surfaces. Thromb Res 15:157
McKay DG (1965) Disseminated intravascular coagulation: An intermediary mechanism of disease. Hoeber Medical Division, Harper and Row, New York, p 392
Minna JD, Robby SJ, Colman RW (1974) Disseminated intravascular coagulation in man. Charles C Thomas, Springfield, Illinois USA, pp 3–18, 26–33
Teger-Nilsson AC (1979) Use of chromogenic substrates for screening of inhibitors of coagulation and fibrinolysis in patients. In: Scully, Kakkar (eds) Chromogenic peptide substrates. Chemistry and clinical usage. Churchill Livingstone, Glasgow, p 269
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hellgren, M., Egberg, N. & Eklund, J. Blood coagulation and fibrinolytic factors and their inhibitors in critically ill patients. Intensive Care Med 10, 23–28 (1984). https://doi.org/10.1007/BF00258064
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00258064